HCA
ABBV icon

Harbour Capital Advisors’s AbbVie ABBV Stock Holding History

Harbour Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$900K Hold
3,627
– – 0.16% 123
2026
Q1 		$727K Buy
3,627
+428
+13% +$94.9K 0.14% 144
2025
Q4 		$734K Buy
3,199
+34
+1% +$7.75K 0.15% 138
2025
Q3 		$737K Buy
3,165
+59
+2% +$12K 0.15% 141
2025
Q2 		$592K Hold
3,106
– – 0.12% 164
2025
Q1 		$626K Sell
3,106
-153
-5% -$29.7K 0.15% 145
2024
Q4 		$591K Hold
3,259
– – 0.13% 152
2024
Q3 		$635K Hold
3,259
– – 0.15% 149
2024
Q2 		$555K Hold
3,259
– – 0.13% 157
2024
Q1 		$589K Hold
3,259
– – 0.15% 152
2023
Q4 		$523K Hold
3,259
– – 0.14% 154
2023
Q3 		$486K Hold
3,259
– – 0.15% 147
2023
Q2 		$440K Sell
3,259
-1,173
-26% -$172K 0.13% 149
2023
Q1 		$706K Buy
4,432
+59
+1% +$9.02K 0.21% 112
2022
Q4 		$710K Sell
4,373
-6
-0.1% -$920 0.24% 95
2022
Q3 		$606K Hold
4,379
– – 0.21% 114
2022
Q2 		$671K Buy
4,379
+50
+1% +$7.64K 0.22% 106
2022
Q1 		$702K Hold
4,329
– – 0.19% 118
2021
Q4 		$586K Hold
4,329
– – 0.14% 134
2021
Q3 		$467K Buy
4,329
+184
+4% +$21K 0.12% 158
2021
Q2 		$467K Hold
4,145
– – 0.13% 153
2021
Q1 		$449K Buy
+4,145
New +$443K 0.13% 147
2020
Q4 		– Sell
-4,145
Closed -$363K – 68
2020
Q3 		$363K Sell
4,145
-3,707
-47% -$349K 0.13% 149
2020
Q2 		$771K Sell
7,852
-2,570
-25% -$226K 0.31% 89
2020
Q1 		$794K Buy
10,422
+2,515
+32% +$214K 0.4% 75
2019
Q4 		$700K Sell
7,907
-95
-1% -$7.89K 0.27% 101
2019
Q3 		$606K Sell
8,002
-56
-0.7% -$3.84K 0.26% 103
2019
Q2 		$586K Sell
8,058
-165
-2% -$13K 0.25% 109
2019
Q1 		$663K Sell
8,223
-240
-3% -$19.6K 0.29% 101
2018
Q4 		$780K Buy
8,463
+221
+3% +$19.4K 0.39% 88
2018
Q3 		$780K Buy
8,242
+186
+2% +$17.6K 0.31% 80
2018
Q2 		$750K Hold
8,056
– – 0.32% 99
2018
Q1 		$763K Sell
8,056
-992
-11% -$109K 0.32% 95
2017
Q4 		$875K Sell
9,048
-1,181
-12% -$111K 0.36% 96
2017
Q3 		$909K Buy
+10,229
New +$779K 0.4% 85
2017
Q2 		– Sell
-1,229
Closed -$80.1K – 238
2017
Q1 		$80.1K Buy
+1,229
New +$77.3K 0.04% 319
2016
Q2 		– Sell
-6,447
Closed -$368K – 224
2016
Q1 		$368K Sell
6,447
-5,263
-45% -$293K 0.21% 151
2015
Q4 		$694K Sell
11,710
-105
-0.9% -$6.05K 0.38% 96
2015
Q3 		$643K Sell
11,815
-8,090
-41% -$527K 0.46% 85
2015
Q2 		$1.34M Hold
19,905
– – 0.83% 23
2015
Q1 		$1.17M Buy
19,905
+1,436
+8% +$86.8K 0.81% 29
2014
Q4 		$1.21M Buy
18,469
+3,500
+23% +$221K 0.87% 25
2014
Q3 		$865K Buy
14,969
+2,785
+23% +$155K 0.71% 43
2014
Q2 		$688K Buy
12,184
+3,915
+47% +$205K 0.54% 73
2014
Q1 		$425K Buy
8,269
+2,400
+41% +$121K 0.4% 91
2013
Q4 		$310K Buy
+5,869
New +$288K 0.27% 129

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Harbour Capital Advisors's ABBV Position: Q2 2026 in Review

Harbour Capital Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 3,627 shares worth $900K. The position accounts for 0.16% of the portfolio, ranked #123.

Harbour Capital Advisors first reported a position in ABBV in Q4 2013 and has held it in 46 quarters since. The position peaked at $1.34M in Q2 2015. 1,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbour Capital Advisors held 3,627 shares of AbbVie worth $900K as of Q2 2026.
  • Harbour Capital Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.16% of Harbour Capital Advisors's portfolio in Q2 2026, its #123 holding.
  • Harbour Capital Advisors first reported a position in AbbVie in Q4 2013 and has held it in 46 quarters since.
  • Harbour Capital Advisors's AbbVie position peaked at $1.34M in Q2 2015.
  • 1,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.